According to Gilead Sciences's latest financial reports the company's total liabilities are HK$309.04 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | HK$308.59 B | 0.35% |
2023-12-31 | HK$307.52 B | -6.2% |
2022-12-31 | HK$327.85 B | -10.33% |
2021-12-31 | HK$365.61 B | -6.02% |
2020-12-31 | HK$389.05 B | 28.16% |
2019-12-31 | HK$303.55 B | -8.01% |
2018-12-31 | HK$330.00 B | -15.15% |
2017-12-31 | HK$388.94 B | 33.35% |
2016-12-31 | HK$291.67 B | 15.43% |
2015-12-31 | HK$252.69 B | 72.88% |
2014-12-31 | HK$146.17 B | 73.99% |
2013-12-31 | HK$84.01 B | -7.33% |
2012-12-31 | HK$90.65 B | 11.85% |
2011-12-31 | HK$81.05 B | 90.38% |
2010-12-31 | HK$42.57 B | 71.95% |
2009-12-31 | HK$24.76 B | 29.66% |
2008-12-31 | HK$19.09 B | 9.61% |
2007-12-31 | HK$17.42 B | 1.03% |
2006-12-31 | HK$17.24 B | 201.15% |
2005-12-31 | HK$5.72 B | 158.46% |
2004-12-31 | HK$2.21 B | -48.2% |
2003-12-31 | HK$4.27 B | -23.5% |
2002-12-31 | HK$5.59 B | 109.41% |
2001-12-31 | HK$2.66 B |